Levocetirizine Dihydrochloride is the dihydrochloride salt form of the active levorotatory enantiomer of cetirizine, levocetirizine; a third generation, non-sedating, selective histamine H1 receptor antagonist, with antihistamine, anti-inflammatory and potential anti-angiogenic activities. Levocetirizine competes with endogenous histamine for binding at peripheral H1-receptor sites on the effector cell surface. This prevents the negative symptoms associated with histamine release and an allergic reaction. In addition, as histamine plays an important role in angiogenesis during an allergic inflammatory reaction, blocking the action of histamine may modulate the expression of proangiogenic factors and thus may prevent angiogenesis. As a third-generation histamine H1 receptor antagonist, levocetirizine has fewer side effects than most second-generation antihistamines.
The global Levocetirizine Dihydrochloride API market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Levocetirizine Dihydrochloride API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Levocetirizine Dihydrochloride API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Levocetirizine Dihydrochloride API include Dr. Reddy’s Laboratories Ltd., Metrochem API Private Limited, Om Pharmaceutical Industries, Symed Labs Limited, Glenmark Pharmaceuticals, Granules India Limited, Chongqing Huapont Pharmaceutical, Glochem Industries and Cipla, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Levocetirizine Dihydrochloride API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Levocetirizine Dihydrochloride API.
The Levocetirizine Dihydrochloride API market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Levocetirizine Dihydrochloride API market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Levocetirizine Dihydrochloride API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Dr. Reddy’s Laboratories Ltd.
Metrochem API Private Limited
Om Pharmaceutical Industries
Symed Labs Limited
Glenmark Pharmaceuticals
Granules India Limited
Chongqing Huapont Pharmaceutical
Glochem Industries
Cipla
Nishchem International Pvt. Ltd
Maps Laboratories Private Limited
Supriya Lifescience Limited
Segment by Type
±Ê³Ü°ù¾±³Ù²â≥98%
Purity<98%
Segment by Application
Levocetirizine Dihydrochloride Tablets
Levocetirizine Dihydrochloride Oral Solution
Others
Production by Region
India
China
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Levocetirizine Dihydrochloride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Levocetirizine Dihydrochloride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Levocetirizine Dihydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Levocetirizine Dihydrochloride API Market Overview
1.1 Product Definition
1.2 Levocetirizine Dihydrochloride API Segment by Type
1.2.1 Global Levocetirizine Dihydrochloride API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 ±Ê³Ü°ù¾±³Ù²â≥98%
1.2.3 Purity<98%
1.3 Levocetirizine Dihydrochloride API Segment by Application
1.3.1 Global Levocetirizine Dihydrochloride API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Levocetirizine Dihydrochloride Tablets
1.3.3 Levocetirizine Dihydrochloride Oral Solution
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Levocetirizine Dihydrochloride API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Levocetirizine Dihydrochloride API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Levocetirizine Dihydrochloride API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Levocetirizine Dihydrochloride API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Levocetirizine Dihydrochloride API Production Market Share by Manufacturers (2018-2023)
2.2 Global Levocetirizine Dihydrochloride API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Levocetirizine Dihydrochloride API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Levocetirizine Dihydrochloride API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Levocetirizine Dihydrochloride API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Levocetirizine Dihydrochloride API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Levocetirizine Dihydrochloride API, Product Offered and Application
2.8 Global Key Manufacturers of Levocetirizine Dihydrochloride API, Date of Enter into This Industry
2.9 Levocetirizine Dihydrochloride API Market Competitive Situation and Trends
2.9.1 Levocetirizine Dihydrochloride API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Levocetirizine Dihydrochloride API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Levocetirizine Dihydrochloride API Production by Region
3.1 Global Levocetirizine Dihydrochloride API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Levocetirizine Dihydrochloride API Production Value by Region (2018-2029)
3.2.1 Global Levocetirizine Dihydrochloride API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Levocetirizine Dihydrochloride API by Region (2024-2029)
3.3 Global Levocetirizine Dihydrochloride API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Levocetirizine Dihydrochloride API Production by Region (2018-2029)
3.4.1 Global Levocetirizine Dihydrochloride API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Levocetirizine Dihydrochloride API by Region (2024-2029)
3.5 Global Levocetirizine Dihydrochloride API Market Price Analysis by Region (2018-2023)
3.6 Global Levocetirizine Dihydrochloride API Production and Value, Year-over-Year Growth
3.6.1 India Levocetirizine Dihydrochloride API Production Value Estimates and Forecasts (2018-2029)
3.6.2 China Levocetirizine Dihydrochloride API Production Value Estimates and Forecasts (2018-2029)
4 Levocetirizine Dihydrochloride API Consumption by Region
4.1 Global Levocetirizine Dihydrochloride API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Levocetirizine Dihydrochloride API Consumption by Region (2018-2029)
4.2.1 Global Levocetirizine Dihydrochloride API Consumption by Region (2018-2023)
4.2.2 Global Levocetirizine Dihydrochloride API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Levocetirizine Dihydrochloride API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Levocetirizine Dihydrochloride API Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Levocetirizine Dihydrochloride API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Levocetirizine Dihydrochloride API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Levocetirizine Dihydrochloride API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Levocetirizine Dihydrochloride API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Levocetirizine Dihydrochloride API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Levocetirizine Dihydrochloride API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Levocetirizine Dihydrochloride API Production by Type (2018-2029)
5.1.1 Global Levocetirizine Dihydrochloride API Production by Type (2018-2023)
5.1.2 Global Levocetirizine Dihydrochloride API Production by Type (2024-2029)
5.1.3 Global Levocetirizine Dihydrochloride API Production Market Share by Type (2018-2029)
5.2 Global Levocetirizine Dihydrochloride API Production Value by Type (2018-2029)
5.2.1 Global Levocetirizine Dihydrochloride API Production Value by Type (2018-2023)
5.2.2 Global Levocetirizine Dihydrochloride API Production Value by Type (2024-2029)
5.2.3 Global Levocetirizine Dihydrochloride API Production Value Market Share by Type (2018-2029)
5.3 Global Levocetirizine Dihydrochloride API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Levocetirizine Dihydrochloride API Production by Application (2018-2029)
6.1.1 Global Levocetirizine Dihydrochloride API Production by Application (2018-2023)
6.1.2 Global Levocetirizine Dihydrochloride API Production by Application (2024-2029)
6.1.3 Global Levocetirizine Dihydrochloride API Production Market Share by Application (2018-2029)
6.2 Global Levocetirizine Dihydrochloride API Production Value by Application (2018-2029)
6.2.1 Global Levocetirizine Dihydrochloride API Production Value by Application (2018-2023)
6.2.2 Global Levocetirizine Dihydrochloride API Production Value by Application (2024-2029)
6.2.3 Global Levocetirizine Dihydrochloride API Production Value Market Share by Application (2018-2029)
6.3 Global Levocetirizine Dihydrochloride API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Dr. Reddy’s Laboratories Ltd.
7.1.1 Dr. Reddy’s Laboratories Ltd. Levocetirizine Dihydrochloride API Corporation Information
7.1.2 Dr. Reddy’s Laboratories Ltd. Levocetirizine Dihydrochloride API Product Portfolio
7.1.3 Dr. Reddy’s Laboratories Ltd. Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Dr. Reddy’s Laboratories Ltd. Main Business and Markets Served
7.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
7.2 Metrochem API Private Limited
7.2.1 Metrochem API Private Limited Levocetirizine Dihydrochloride API Corporation Information
7.2.2 Metrochem API Private Limited Levocetirizine Dihydrochloride API Product Portfolio
7.2.3 Metrochem API Private Limited Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Metrochem API Private Limited Main Business and Markets Served
7.2.5 Metrochem API Private Limited Recent Developments/Updates
7.3 Om Pharmaceutical Industries
7.3.1 Om Pharmaceutical Industries Levocetirizine Dihydrochloride API Corporation Information
7.3.2 Om Pharmaceutical Industries Levocetirizine Dihydrochloride API Product Portfolio
7.3.3 Om Pharmaceutical Industries Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Om Pharmaceutical Industries Main Business and Markets Served
7.3.5 Om Pharmaceutical Industries Recent Developments/Updates
7.4 Symed Labs Limited
7.4.1 Symed Labs Limited Levocetirizine Dihydrochloride API Corporation Information
7.4.2 Symed Labs Limited Levocetirizine Dihydrochloride API Product Portfolio
7.4.3 Symed Labs Limited Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Symed Labs Limited Main Business and Markets Served
7.4.5 Symed Labs Limited Recent Developments/Updates
7.5 Glenmark Pharmaceuticals
7.5.1 Glenmark Pharmaceuticals Levocetirizine Dihydrochloride API Corporation Information
7.5.2 Glenmark Pharmaceuticals Levocetirizine Dihydrochloride API Product Portfolio
7.5.3 Glenmark Pharmaceuticals Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Glenmark Pharmaceuticals Main Business and Markets Served
7.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
7.6 Granules India Limited
7.6.1 Granules India Limited Levocetirizine Dihydrochloride API Corporation Information
7.6.2 Granules India Limited Levocetirizine Dihydrochloride API Product Portfolio
7.6.3 Granules India Limited Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Granules India Limited Main Business and Markets Served
7.6.5 Granules India Limited Recent Developments/Updates
7.7 Chongqing Huapont Pharmaceutical
7.7.1 Chongqing Huapont Pharmaceutical Levocetirizine Dihydrochloride API Corporation Information
7.7.2 Chongqing Huapont Pharmaceutical Levocetirizine Dihydrochloride API Product Portfolio
7.7.3 Chongqing Huapont Pharmaceutical Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Chongqing Huapont Pharmaceutical Main Business and Markets Served
7.7.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
7.8 Glochem Industries
7.8.1 Glochem Industries Levocetirizine Dihydrochloride API Corporation Information
7.8.2 Glochem Industries Levocetirizine Dihydrochloride API Product Portfolio
7.8.3 Glochem Industries Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Glochem Industries Main Business and Markets Served
7.7.5 Glochem Industries Recent Developments/Updates
7.9 Cipla
7.9.1 Cipla Levocetirizine Dihydrochloride API Corporation Information
7.9.2 Cipla Levocetirizine Dihydrochloride API Product Portfolio
7.9.3 Cipla Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Cipla Main Business and Markets Served
7.9.5 Cipla Recent Developments/Updates
7.10 Nishchem International Pvt. Ltd
7.10.1 Nishchem International Pvt. Ltd Levocetirizine Dihydrochloride API Corporation Information
7.10.2 Nishchem International Pvt. Ltd Levocetirizine Dihydrochloride API Product Portfolio
7.10.3 Nishchem International Pvt. Ltd Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Nishchem International Pvt. Ltd Main Business and Markets Served
7.10.5 Nishchem International Pvt. Ltd Recent Developments/Updates
7.11 Maps Laboratories Private Limited
7.11.1 Maps Laboratories Private Limited Levocetirizine Dihydrochloride API Corporation Information
7.11.2 Maps Laboratories Private Limited Levocetirizine Dihydrochloride API Product Portfolio
7.11.3 Maps Laboratories Private Limited Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Maps Laboratories Private Limited Main Business and Markets Served
7.11.5 Maps Laboratories Private Limited Recent Developments/Updates
7.12 Supriya Lifescience Limited
7.12.1 Supriya Lifescience Limited Levocetirizine Dihydrochloride API Corporation Information
7.12.2 Supriya Lifescience Limited Levocetirizine Dihydrochloride API Product Portfolio
7.12.3 Supriya Lifescience Limited Levocetirizine Dihydrochloride API Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Supriya Lifescience Limited Main Business and Markets Served
7.12.5 Supriya Lifescience Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Levocetirizine Dihydrochloride API Industry Chain Analysis
8.2 Levocetirizine Dihydrochloride API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Levocetirizine Dihydrochloride API Production Mode & Process
8.4 Levocetirizine Dihydrochloride API Sales and Marketing
8.4.1 Levocetirizine Dihydrochloride API Sales Channels
8.4.2 Levocetirizine Dihydrochloride API Distributors
8.5 Levocetirizine Dihydrochloride API Customers
9 Levocetirizine Dihydrochloride API Market Dynamics
9.1 Levocetirizine Dihydrochloride API Industry Trends
9.2 Levocetirizine Dihydrochloride API Market Drivers
9.3 Levocetirizine Dihydrochloride API Market Challenges
9.4 Levocetirizine Dihydrochloride API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Dr. Reddy’s Laboratories Ltd.
Metrochem API Private Limited
Om Pharmaceutical Industries
Symed Labs Limited
Glenmark Pharmaceuticals
Granules India Limited
Chongqing Huapont Pharmaceutical
Glochem Industries
Cipla
Nishchem International Pvt. Ltd
Maps Laboratories Private Limited
Supriya Lifescience Limited
Ìý
Ìý
*If Applicable.
